ENSC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Ensysce Biosciences Inc (ENSC) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company is experiencing significant financial deterioration, with revenue, net income, and EPS showing sharp declines. Technical indicators are bearish, and there are no strong positive catalysts or trading signals to suggest a favorable entry point. The stock's short-term potential for minor gains does not align with the user's long-term investment goals.
The technical indicators show a bearish trend. The MACD histogram is negative and contracting, RSI is neutral at 27.197, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with the nearest support at 0.408 and resistance at 0.547.
NULL identified. There are no significant positive news or events directly related to ENSC.
Additionally, there are no hedge fund or insider trading trends to suggest confidence in the stock.
In Q3 2025, the company's revenue dropped by 85.58% YoY to $493,104. Net income fell by 663.51% YoY to -$3,729,128, and EPS declined by 229.00% YoY to -1.29. Gross margin remained flat at 100%. These figures indicate severe financial challenges.
No analyst rating or price target data available for ENSC.
